(Q45292937)

11 December 2017

Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease (English)

1 reference

11 December 2017

0 references

2

1 reference

11 December 2017

8

1 reference

11 December 2017

9

1 reference

11 December 2017

Gerard R Ridgway

5

0 references

Roger A. Barker

object named as

Roger A Barker

series ordinal

7

0 references

Rachael I. Scahill

series ordinal

4

object named as

Rachael I Scahill

1 reference

11 December 2017

1

Susie M D Henley

1 reference

11 December 2017

Nicola Z Hobbs

3

1 reference

PubMed ID

19266143

11 December 2017

David G Macmanus

series ordinal

6

1 reference

11 December 2017

1 February 2009

1 reference

11 December 2017

1 reference

11 December 2017

256

1 reference

11 December 2017

203-212

1 reference

11 December 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s00415-009-0052-x

11 December 2017

0 references

cites work

Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-0052-X

Longitudinal change in basal ganglia volume in patients with Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-0052-X

Striatal volume loss in HD as measured by MRI and the influence of CAG repeat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-0052-X

Regional and progressive thinning of the cortical ribbon in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-0052-X

Huntington disease: Clinical care and evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-0052-X

The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy.

21 January 2018

1 reference

12 December 2020

Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease

1 reference

12 December 2020

Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI.

1 reference

12 December 2020

Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease

1 reference

12 December 2020

Triplet repeat mutation length gains correlate with cell-type specific vulnerability in Huntington disease brain

1 reference

12 December 2020

Does CAG repeat number predict the rate of pathological changes in Huntington's disease?

1 reference

12 December 2020

Variation of selective gray and white matter atrophy in Huntington's disease

1 reference

12 December 2020

Regional specificity of brain atrophy in Huntington's disease.

1 reference

12 December 2020

Clinical presentation and patterns of regional cerebral atrophy related to the length of trinucleotide repeat expansion in patients with adult onset Huntington's disease

1 reference

12 December 2020

Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging.

1 reference

12 December 2020

Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans.

1 reference

12 December 2020

Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study.

1 reference

12 December 2020

Striatal gray matter loss in Huntington's disease is leftward biased

1 reference

12 December 2020

Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.

1 reference

12 December 2020

Brain structure in preclinical Huntington's disease.

1 reference

12 December 2020

Global cerebral atrophy in early stages of Huntington's disease: quantitative MRI study

1 reference

12 December 2020

A voxel-based morphometric study of ageing in 465 normal adult human brains

1 reference

12 December 2020

Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study.

1 reference

12 December 2020

The distribution of structural neuropathology in pre-clinical Huntington's disease

1 reference

12 December 2020

Regional cortical thinning in preclinical Huntington disease and its relationship to cognition

1 reference

12 December 2020

Neuropathological classification of Huntington's disease

1 reference

12 December 2020

Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat.

1 reference

12 December 2020

Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study.

1 reference

12 December 2020

Striatal and extrastriatal atrophy in Huntington's disease and its relationship with length of the CAG repeat

1 reference

12 December 2020

CAG repeat number governs the development rate of pathology in Huntington's disease

1 reference

12 December 2020

Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI.

1 reference

12 December 2020

Neural correlates of semantic and behavioural deficits in frontotemporal dementia

1 reference

12 December 2020

Voxel-based morphometry indicates relative preservation of the limbic prefrontal cortex in early Huntington disease

1 reference

12 December 2020

Unified Huntington's disease rating scale: Reliability and consistency

1 reference

12 December 2020

Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis

1 reference

12 December 2020

Voxel-based morphometry–the methods

1 reference

12 December 2020

10.1007/S00415-009-0052-X

Identifiers

DOI

1 reference

PubMed ID

19266143

Dimensions Publication ID

11 December 2017

0 references

1 reference

PubMed ID

19266143